title: Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa.
abstract: BACKGROUND
  Anorexia nervosa is highly prevalent among young women.
  
  
  OBJECTIVE
  To determine prevalence and predictive factors for regional bone loss.
  
  
  METHODS
  Prospective cohort analysis.
  
  
  METHODS
  University hospital.
  
  
  METHODS
  130 women with anorexia nervosa.
  
  
  METHODS
  Dual-energy x-ray absorptiometry.
  
  
  RESULTS
  The prevalence of osteopenia (-1.0 SD >/= T-score > -2.5 SD) and osteoporosis (T-score </= -2.5 SD) was 50% and 13% for the anterior-posterior spine, 57% and 24% for the lateral spine, and 47% and 16% for the total hip, respectively. Bone mineral density (BMD) was reduced by at least 1.0 SD at one or more skeletal sites in 92% of patients and by at least 2.5 SD in 38% of patients. Weight was the most consistent predictor of BMD at all skeletal sites. Twenty-three percent of patients were current estrogen users, and 58% were previous estrogen users. Bone mineral density did not differ by history of estrogen use at any site.
  
  
  CONCLUSIONS
  Bone mineral density is reduced at several skeletal sites in most women with anorexia nervosa. Weight, but not estrogen use, is a significant predictor of BMD in this population at all skeletal sites.
authors.affiliation: Neuroendocrine Unit, Bulfinch 457b, Massachusetts General Hospital, Boston, MA 02114, USA.
authors.forename: S
authors.initials: S
authors.lastname: Grinspoon
authors.forename: E
authors.initials: E
authors.lastname: Thomas
authors.forename: S
authors.initials: S
authors.lastname: Pitts
authors.forename: E
authors.initials: E
authors.lastname: Gross
authors.forename: D
authors.initials: D
authors.lastname: Mickley
authors.forename: K
authors.initials: K
authors.lastname: Miller
authors.forename: D
authors.initials: D
authors.lastname: Herzog
authors.forename: A
authors.initials: A
authors.lastname: Klibanski
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D000367:Age Factors; D000856:Anorexia Nervosa / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000453:epidemiology* / Q000209:etiology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008572:Menarche; D010024:Osteoporosis / Q000453:epidemiology / Q000209:etiology; D015995:Prevalence; D011446:Prospective Studies; D012044:Regression Analysis